Extrusion and spheronization in the development of oral controlled-release dosage forms
- 1 April 1999
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 2 (4), 160-170
- https://doi.org/10.1016/s1461-5347(99)00136-4
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Development and in-vitro evaluation of matrix based CR pellets for Diltiazem HC***1 using extrusion and spheronizationJournal of Pharmacy and Pharmacology, 1998
- The Use of β-Cyclodextrin as a Pelletization Agent in the Extrusion/ Spheronization ProcessDrug Development and Industrial Pharmacy, 1998
- Oral Controlled Release Dosage Forms. II. Glassy Polymers in Hydrophilic MatricesDrug Development and Industrial Pharmacy, 1998
- Formulation and preparation of controlled release pellets of salbutamol by the air suspension techniqueJournal of Microencapsulation, 1997
- In vitrocharacterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension techniqueJournal of Microencapsulation, 1997
- Comparison of two commercial brands of microcrystalline cellulose for extrusion-spheronizationJournal of Microencapsulation, 1997
- Fabrication and characterization of extruded and spheronized beads containing carbopol® 974P, NF resinInternational Journal of Pharmaceutics, 1996
- Pelletization in Rotary Shaker Effect of Equipment Variables on Pelletization of Ferrous FumarateDrug Development and Industrial Pharmacy, 1995
- Controlled Drug Delivery of Ph Dependent Soluble Drug-PindololDrug Development and Industrial Pharmacy, 1994
- Spheronization II: Drug Release from Drug-Diluent MixturesDrug Development and Industrial Pharmacy, 1985